A Massachusetts campaign to put psychedelics legalization on the 2024 ballot has decided to pursue a version of the initiative that would allow for home...
The DMT drug appeared more effective when combined with SSRIs. The post Small Pharma Sees Promise Pairing DMT Drug with Antidepressants appeared first...
Topline results from Small Pharma's Phase Ib study exploring the interaction between SSRIs and SPL026, the company’s DMT drug. The post Positive Data...
Efficacy Chart Efficacy results in both cohorts at baseline and at Week 4 following the dose of SPL026 with support therapy • Results...
SAFER Banking vote this week; GOP rescheduling block; NCAA marijuana move; WY ballot dispute; Ramaswamy: Expand DEA; WI legalization; MI psychedelics Subscribe to...
Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing...
–Phase 2 topline efficacy data for CYB003 on track for Q4 2023, followed by U.S. Food and Drug Administration (“FDA”) submission of CYB003 Phase...
This has been a busy quarter for the psychedelic industry, particularly Lucy Scientific Discovery Inc. The company has announced three acquisitions in...
California lawmakers delivered a slew of marijuana and psychedelics bills to the governor as the session came to a close last week, and now the question...
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,... The post Glancy Prongay...